TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 SEK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
190,666
|
191,783
|
149,810 |
| Financial expenses |
146
|
103
|
95 |
| Earnings before taxes |
15,723
|
49,230
|
38,496 |
| EBITDA |
16,205
|
49,766
|
39,036 |
| Total assets |
86,149
|
102,545
|
73,472 |
| Current assets |
68,496
|
99,319
|
72,137 |
| Current liabilities |
36,579
|
40,448
|
29,714 |
| Equity capital |
45,236
|
57,763
|
39,424 |
| - share capital |
63
|
63
|
63 |
| Employees (average) |
82
|
71
|
61 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
52.5%
|
56.3%
|
53.7% |
| Turnover per employee |
2,325
|
2,701
|
2,456 |
| Profit as a percentage of turnover |
8.2%
|
25.7%
|
25.7% |
| Return on assets (ROA) |
18.4%
|
48.1%
|
52.5% |
| Current ratio |
187.3%
|
245.5%
|
242.8% |
| Return on equity (ROE) |
34.8%
|
85.2%
|
97.6% |
| Change turnover |
-1,117
|
41,973
|
45,213 |
| Change turnover % |
-1%
|
28%
|
43% |
| Chg. No. of employees |
11
|
10
|
6 |
| Chg. No. of employees % |
15%
|
16%
|
11% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.